When do vascular surgeons prescribe antiplatelet therapy? Current attitudes
- 1 January 1993
- journal article
- review article
- Published by Elsevier in European Journal of Vascular Surgery
- Vol. 7 (1) , 6-13
- https://doi.org/10.1016/s0950-821x(05)80535-3
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Aspirin in Cardiovascular DiseaseDrugs, 1988
- Aspirin and venous occlusion: Effects on blood fibrinolytic activity and tissue-type plasminogen activator levelsThrombosis Research, 1986
- Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man.Journal of Clinical Investigation, 1983
- Regulation of arachidonate-induced platelet aggregation by the lipoxygenase product, 12-hydroperoxyeicosatetraenoic acidBiochimica et Biophysica Acta (BBA) - General Subjects, 1982
- Platelet recovery from aspirin inhibition in vivo; differing patterns under various assay conditionsBlood, 1981
- Recovery of Endothelial Cell Prostacyclin Production after Inhibition by Low Doses of AspirinJournal of Clinical Investigation, 1979
- Inhibition of platelet prostaglandin synthetase by oral aspirin.Journal of Clinical Investigation, 1978
- Cultured human skin fibroblasts and arterial cells produce a labile platelet-inhibitory prostaglandinBiochemical and Biophysical Research Communications, 1977
- An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregationNature, 1976
- The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein.Journal of Clinical Investigation, 1975